These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30136415)

  • 1. Ridge estimation of network models from time-course omics data.
    Miok V; Wilting SM; van Wieringen WN
    Biom J; 2019 Mar; 61(2):391-405. PubMed ID: 30136415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ridge estimation of the VAR(1) model and its time series chain graph from multivariate time-course omics data.
    Miok V; Wilting SM; van Wieringen WN
    Biom J; 2017 Jan; 59(1):172-191. PubMed ID: 27902843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstruction of molecular network evolution from cross-sectional omics data.
    Aflakparast M; de Gunst MCM; van Wieringen WN
    Biom J; 2018 May; 60(3):547-563. PubMed ID: 29320604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-375 Modulates Radiosensitivity of HR-HPV-Positive Cervical Cancer Cells by Targeting UBE3A through the p53 Pathway.
    Song L; Liu S; Zeng S; Zhang L; Li X
    Med Sci Monit; 2015 Jul; 21():2210-7. PubMed ID: 26224081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation.
    Razani B; Altschuler Y; Zhu L; Pestell RG; Mostov KE; Lisanti MP
    Biochemistry; 2000 Nov; 39(45):13916-24. PubMed ID: 11076533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of dormancy in hypoxic human papillomavirus-positive cancer cells.
    Hoppe-Seyler K; Bossler F; Lohrey C; Bulkescher J; Rösl F; Jansen L; Mayer A; Vaupel P; Dürst M; Hoppe-Seyler F
    Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E990-E998. PubMed ID: 28115701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis.
    Habbous S; Pang V; Eng L; Xu W; Kurtz G; Liu FF; Mackay H; Amir E; Liu G
    Clin Cancer Res; 2012 Dec; 18(23):6407-15. PubMed ID: 23065429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of p53 and HPV in cervical cancer.
    Street D; Delgado G
    Gynecol Oncol; 1995 Sep; 58(3):287-8. PubMed ID: 7672693
    [No Abstract]   [Full Text] [Related]  

  • 10. p53 polymorphism and risk of cervical cancer.
    Josefsson AM; Magnusson PK; Ylitalo N; Quarforth-Tubbin P; Pontén J; Adami HO; Gyllensten UB
    Nature; 1998 Dec; 396(6711):531; author reply 532. PubMed ID: 9859988
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo.
    Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW
    Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus (HPV) 16 E6 sensitizes cells to atractyloside-induced apoptosis: role of p53, ICE-like proteases and the mitochondrial permeability transition.
    Brown J; Higo H; McKalip A; Herman B
    J Cell Biochem; 1997 Aug; 66(2):245-55. PubMed ID: 9213225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix.
    Grace VM; Shalini JV; lekha TT; Devaraj SN; Devaraj H
    Gynecol Oncol; 2003 Oct; 91(1):51-8. PubMed ID: 14529662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways.
    Talora C; Cialfi S; Segatto O; Morrone S; Kim Choi J; Frati L; Paolo Dotto G; Gulino A; Screpanti I
    Exp Cell Res; 2005 May; 305(2):343-54. PubMed ID: 15817159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk human papillomavirus, tumor suppressor protein p53 and mitomycin-C in invasive squamous cell carcinoma cervix.
    Rajaram S; Gupta G; Agarwal S; Goel N; Singh KC
    Indian J Cancer; 2006; 43(4):156-62. PubMed ID: 17192686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The state of p53 in primary human cervical carcinomas and its effects in human papillomavirus-immortalized human cervical cells.
    Chen TM; Chen CA; Hsieh CY; Chang DY; Chen YH; Defendi V
    Oncogene; 1993 Jun; 8(6):1511-8. PubMed ID: 8389030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression.
    Uren A; Fallen S; Yuan H; Usubütün A; Küçükali T; Schlegel R; Toretsky JA
    Cancer Res; 2005 Jul; 65(14):6199-206. PubMed ID: 16024621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papillomavirus and p53.
    zur Hausen H
    Nature; 1998 May; 393(6682):217. PubMed ID: 9607756
    [No Abstract]   [Full Text] [Related]  

  • 20. pwOmics: an R package for pathway-based integration of time-series omics data using public database knowledge.
    Wachter A; Beißbarth T
    Bioinformatics; 2015 Sep; 31(18):3072-4. PubMed ID: 26002883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.